This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

October 25–28, 2021
Delivered DigitallyCentral European Time
Menu
Register
Key Sessions
Phyllis Arthur
COVID-19 therapeutics: Modality, efficacy and implications for access
Biotechnology Innovation Organization (BIO)
keyboard_arrow_right

Day 4 - Live Sessions

keyboard_arrow_leftSearch & Filter
search

Day 4 - Live Sessions

search
On Demand
Networking
BIO-Europe Digital 2020 Networking: Introducing the 24/7 Café
    10:00 - 10:3030 mins
    Networking
    BIO-Europe Digital 2020 Networking: Long-lasting partnerships are like happy marriages
    • Urs Schleuniger - Global Head Alliance & Asset Management, Roche Pharma Partnering
    11:00 - 12:0060 mins
    Additional Program
    EIT Health Headstart : Cohort A
    • Sebastião van Uden - CEO, Bac3Gel
    • Sara Lobo - Co-founder and CMO, C-mo Medical Solutions
    • Cornel Amariei - Founder, DOTLUMEN
    • Massimiliano Clamer - Founder and President, IMMAGINA BioTechnology
    • Alfonso Maria Ponsiglione - Co-founder and COO, Kyme NanoImaging
    • David Breitenbach - Co-founder, Sineko Global
    • Ivan Porro - Founder and CEO, SurgiQ
    • Daniele Conti - Co-founder and CEO, SYNDIAG
    15:30 - 16:1545 mins
    Additional Program
    EIT Health Headstart : Cohort B
    • Eugene Nayshtetik - Founder and Managing Partner, Lorton Investments - SenceBand
    • Katarzyna Zimoląg - CEO, i-Care
    • Riccardo Piccioli - Co-founder and CEO, Mysurable
    17:00 - 18:0060 mins
    Plenary
    COVID-19 therapeutics: Modality, efficacy and implications for access
    • Phyllis Arthur - VP, Infectious Disease and Vaccine Policy, Biotechnology Innovation Organization (BIO)
    • David Thomas - VP, Industry Research and Analysis, Biotechnology Industry Organization (BIO)
    • Richard Marsden - CEO, Synairgen
    • Neil Mulcock - VP, Government Affairs, EMEA, Gilead Sciences
    • Kylie O'Keefe - VP, Global Commercial Strategy, PTC Therapeutics
    • Gregg Szabo - VP and Commercial Leader, Virology/Immunology, MSD
    Day 3 - Live Sessions
    Filter
    Streams
    Formats
    Topics
    Choose Day